Alternative Therapies in the Treatment of Chemotherapy-Induced Nausea and Vomiting

  • Jørn Herrstedt
Conference paper
Part of the ESO Monographs book series (ESO MONOGRAPHS)

Abstract

Although it is generally recognised that unorthodox therapies have no objective antitumor activity [1], it is estimated that 30–50% of cancer patients use these unproven methods either alone or along with established cancer therapies [2,3]. Physicians therefore have to be acquainted with alternative therapies, which will only disappear when the majority of malignancies are cured. A large proportion of patients using alternative therapies do so in an attempt to improve resistance and quality of life by mitigating the side-effects of chemotherapy or radiotherapy [3].

Keywords

Placebo Oncol Dexamethasone Methotrexate Cyclophosphamide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jallut OB: What can be done against unproven methods in cancer therapy. The Swiss experience. J Cancer Res Clin Oncol 1990 (116, Suppl, Part II):S950Google Scholar
  2. 2.
    Kjaer M: Unproven methods in cancer therapy in Denmark and Scandinavia. J Cancer Res Clin Oncol 1990 (116, Suppl, Part II):S949Google Scholar
  3. 3.
    Jungi WF: Alternative medicine (AM) in the German-speaking countries in Europe. J Cancer Res Clin Oncol 1990 (116, Suppl, Part ll):S949Google Scholar
  4. 4.
    Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM, Tattersall MHN: On the receiving end — patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983 (19):203–208PubMedCrossRefGoogle Scholar
  5. 5.
    Richardson JL, Marks G, Levine A: The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. J Clin Oncol 1988(6):1746–1752PubMedGoogle Scholar
  6. 6.
    Roila F, Tonato M, Cognetti F et al: Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991 (9):675–678PubMedGoogle Scholar
  7. 7.
    Smyth JF, Coleman RE, Nicolson M et al: Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? Br Med J 1991 (303): 1423–1426CrossRefGoogle Scholar
  8. 8.
    Smith DB, Newlands ES, Rustin GJS et al: Comparison of ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 1991 (338):487–490PubMedCrossRefGoogle Scholar
  9. 9.
    Herrstedt J, Sigsgaard T, Boesgaard M, Jensen TP, Dombernowsky: Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy. N Engl J Med 1993 (328): 1076–1080PubMedCrossRefGoogle Scholar
  10. 10.
    Lewith GT, Lewith NR. Modern Chinese Acupuncture. Thorsons Publishers Ltd, Wellingborough 1980Google Scholar
  11. 11.
    Lewith GT, Machin D: On the evaluation of the clinical effects of acupuncture. Pain 1983 (16):111–127PubMedCrossRefGoogle Scholar
  12. 12.
    Chestnutt WN, Dundee JW: Acupuncture for relief of meptanozol-induced vomiting. Br J Anaesth 1985 (57):825P–826PGoogle Scholar
  13. 13.
    Dundee JW, Chestnutt WN, Ghaly RG, Lynas AGA: Traditional Chinese acupuncture: a potentially useful antiemetic? Br Med J 1986 (293):583–584CrossRefGoogle Scholar
  14. 14.
    Dundee JW, Fitzpatrick KTJ, Ghaly RG, Patterson CC: Does dextrality or sinistrality affect the outcome of P6 acupuncture anti-emesis? Br J Clin Pharmacol 1988 (25):679P–680PGoogle Scholar
  15. 15.
    Ghaly RG, Fitzpatrick KTJ, Dundee JW: Antiemetic studies with traditional Chinese acupuncture. A comparison of manual needling with electrical stimulation and commonly used antiemetics. Anaesthesia 1987 (42): 1108–1110PubMedCrossRefGoogle Scholar
  16. 16.
    Fry ENS: Acupressure and postoperative vomiting. Anaesthesia 1986 (41):661–662PubMedCrossRefGoogle Scholar
  17. 17.
    Weightman WM, Zacharias M, Herbison P: Traditional Chinese acupuncture as an antiemetic. Br Med J 1987 (295): 1379–1380CrossRefGoogle Scholar
  18. 18.
    Dundee JW, Milligan KR: Acupuncture as an antiemetic. Br Med J 1988 (296): 135CrossRefGoogle Scholar
  19. 19.
    Fassoulaki A, Papilas K, Sarantopoulos C, Zotou M: Transcutaneous electrical nerve stimulation reduces the incidence of vomiting after hysterectomy. Anesth Analg 1993 (76):1012–1014PubMedCrossRefGoogle Scholar
  20. 20.
    Dundee JW, Ghaly RG, Fitzpatrick KTJ: Randomised comparison of the antiemetic effects of meto-clopramide and electroacupuncture in cancer chemotherapy. Br J Clin Pharmacol 1988 (25):678P–679PGoogle Scholar
  21. 21.
    Moertel CG, Reitemeier RJ: Controlled clinical studies of orally administered antiemetic drugs. Gastroenterology 1969 (57):262–268PubMedGoogle Scholar
  22. 22.
    Morran C, Smith DC, Anderson DA, McArdle CS: Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics. Br Med J 1979 (1): 1323–1324PubMedCrossRefGoogle Scholar
  23. 23.
    Fetting JH, Grochow LB, Folstein MF, Ettinger DS, Colvin M: The course of nausea and vomiting after high-dose cyclophosphamide. Cancer Treat Rep 1982 (66): 1487–1493PubMedGoogle Scholar
  24. 24.
    Dundee JW, Ghaly RH, Fitzpatrick KTJ, Abram WP, Lynch GA: Acupuncture prophylaxis of cancer chemotherapy-induced sickness. J Roy Soc Med 1989(82):268–271PubMedGoogle Scholar
  25. 25.
    Dundee JW, Ghaly RG, Fitzpatrick KTJ, Lynch GA, Abram WP: Acupuncture to prevent cisplatin-associated vomiting. Lancet 1987 (1):1083PubMedCrossRefGoogle Scholar
  26. 26.
    Dundee JW, Yang J: Prolongation of the antiemetic action of P6 acupuncture by acupressure in patients having cancer chemotherapy. J Roy Soc Med 1990 (83):360–362PubMedGoogle Scholar
  27. 27.
    Aglietti L, Roila F, Tonato M et al: A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatin. Cancer Chemother Pharmacol 1990 (26):239–240PubMedCrossRefGoogle Scholar
  28. 28.
    Sailer R, Hellenbrecht D, Bühring M, Hess H: Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulation. J Clin Pharmacol 1986 (26):115–119Google Scholar
  29. 29.
    Sailer R, Hellenbrecht D, Hellstem A, Hess H: Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis. Eur J Clin Pharmacol 1985 (29):311–312CrossRefGoogle Scholar
  30. 30.
    Redd WH, Andrykowski MA: Behavioral intervention in cancer treatment: controlling aversion reactions to chemotherapy. J Consult Clin Psychol 1982 (50):1018–1029PubMedCrossRefGoogle Scholar
  31. 31.
    Cotanch PH: Relaxation techniques as antiemetic therapy. In: Laszlo J (ed) Antiemetic and Cancer Chemotherapy. Williams & Wilkins, Baltimore/ London 1983 pp 164–176Google Scholar
  32. 32.
    Pratt A, Lazar RM, Penman D, Holland JC: Psychological parameters of chemotherapy-induced conditioned nausea and vomiting: a review. Cancer Nurs 1984(Dec):483–490Google Scholar
  33. 33.
    Morrow GR, Dobkin PL: Anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment: prevalence, etiology, and behavioral interventions. Clin Psychol Rev 1988 (8):517–556CrossRefGoogle Scholar
  34. 34.
    Carey MP, Burish TG: Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion. Psychol Bulletin 1988 (104):307–325CrossRefGoogle Scholar
  35. 35.
    Redd WH, Silberfarb PM, Andersen BL et al: Physiologic and psychobehavioral research in oncology. Cancer 1991 (67):813–822PubMedCrossRefGoogle Scholar
  36. 36.
    Trijsburg RW, Van Knippenberg FCE: Effects of psychological treatment on cancer patients: a critical review. Psychosomatic Medicine 1992 (54):489–517PubMedGoogle Scholar
  37. 37.
    Wilcox PM, Fetting JH, Nettesheim KM, Abeloff MD: Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF), adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep 1982 (66): 1601–1604PubMedGoogle Scholar
  38. 38.
    Morrow GR: Prevalence and correlates of anticipatory nausea and vomiting during chemotherapy. UNCI 1982 (68):585–588Google Scholar
  39. 39.
    Cohen RE, Blanchard EB, Ruckdeschel JC, Smolen RC: Prevalence and correlates of posttreatment and anticipatory nausea and vomiting in cancer chemotherapy. J Psychosomatic Res 1986 (30): 643–654CrossRefGoogle Scholar
  40. 40.
    Fetting JH, Wilcox PM, Iwata BA et al: Anticipatory nausea and vomiting in an ambulatory medical oncology population. Cancer Treat Rep 1983 (67): 1093–1098PubMedGoogle Scholar
  41. 41.
    Leventhal H, Easterling DV, Nerenz DR, Love RR: The role of motion sickness in predicting anticipatory nausea. J Behav Med 1988 (11):117–130PubMedCrossRefGoogle Scholar
  42. 42.
    Morrow GR: Susceptibility to motion sickness and the development of anticipatory nausea and vomiting in cancer patients. Cancer Treat Rep 1984 (68):99–100Google Scholar
  43. 43.
    Andrykowski MA, Redd WH: Development of anticipatory nausea: a prospective analysis. J Consult Clin Psychol 1985 (53):447–454PubMedCrossRefGoogle Scholar
  44. 44.
    Andrykowski MA, Jacobsen PB, Marks E et al: Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer. Cancer 1988 (62):2607–2613PubMedCrossRefGoogle Scholar
  45. 45.
    Bovbjerg DH, Redd WH, Jacobson PB et al: An experimental analysis of classically conditioned nausea during cancer chemotherapy. Psychosomatic Med 1992 (54):623–637Google Scholar
  46. 46.
    Burish TG, Carey MP: Conditioned aversive responses in cancer chemotherapy patients: theoretical and developmental analysis. J Consult Clin Psychol 1986 (54):593–600PubMedCrossRefGoogle Scholar
  47. 47.
    Dahlquist LM, Gil KM, Armstrong FD, Ginsberg FD, Jones B: Behavioral management of children’s distress during chemotherapy. J Behav Ther Exp Psychiatry 1985 (16):325–329PubMedCrossRefGoogle Scholar
  48. 48.
    Burish TG, Shartner CD, Lyles JN: Effectiveness of multiple-site EMG biofeedback and relaxation in reducing the aversiveness of cancer chemotherapy. Biofeedback and Seifregulation 1981 (6):523–535CrossRefGoogle Scholar
  49. 49.
    Burish TG, Lyles JN: Effectiveness of relaxation training in reducing the aversiveness of chemotherapy in the treatment of cancer. J Behav Ther Exp Psychiatry 1979 (10):357–361CrossRefGoogle Scholar
  50. 50.
    Dempster CR, Balson P, Whalen BT: Supportive hypnotherapy during the radical treatment of malignancies. Int J Clin Exp Hypnosis 1976 (24):1–9CrossRefGoogle Scholar
  51. 51.
    LaClave LJ, Blix S: Hypnosis in the management of symptoms in a young girl with malignant astrocytoma: a challenge to the therapist. Int J Clin Exp Hypnosis 1989 (37):6–14CrossRefGoogle Scholar
  52. 52.
    Kaye JM: Use of hypnosis in the treatment of cancer patients. J Psychosoc Oncology 1987 (5): 11–22CrossRefGoogle Scholar
  53. 53.
    Booraem CD, Flowers JV, Gumbiner J: Combined medical and psychological treatment of postchemo-therapy nausea and vomiting: a case study. Psychological Rep 1989 (65): 187–193CrossRefGoogle Scholar
  54. 54.
    Greene PG, Seime RJ: Stimulus control of anticipatory nausea in cancer chemotherapy. J Behav Ther Exp Psychiatry 1987 (18):61–64PubMedCrossRefGoogle Scholar
  55. 55.
    Olness K: Imagery (self-hypnosis) as adjunct therapy in childhood cancer. Am J Pediatric Hematol-ogy/Oncology 1981 (3):313–321Google Scholar
  56. 56.
    Hockenberry MJ, Cotanch PH: Hypnosis as adjuvant antiemetic therapy in childhood cancer. Nurs Clin North Am 1985 (20):105–107PubMedGoogle Scholar
  57. 57.
    Zeltzer L, Kellerman J, Ellenberg L, Dash J: Hypnosis for reduction of vomiting associated with chemotherapy and disease in adolescents with cancer. J Adolescent Health Care 1983 (4):77–84CrossRefGoogle Scholar
  58. 58.
    LeBaron S, Zeltzer L: Behavioral intervention for reducing chemotherapy-related nausea and vomiting in adolescents with cancer. J Adolescent Health Care 1984 (5):178–182CrossRefGoogle Scholar
  59. 59.
    Zeltzer L, LeBaron S, Zeltzer PM: The effectiveness of behavioral intervention for reduction of nausea and vomiting in children and adolescents receiving chemotherapy. J Clin Oncol 1984 (2):683–690PubMedGoogle Scholar
  60. 60.
    Zeltzer L, Dolgin MJ, LeBaron S, LeBaron C: A randomised, controlled study of behavioral intervention for chemotherapy distress in children with cancer. Pediatrics 1991 (88):34–42PubMedGoogle Scholar
  61. 61.
    Cotanch P, Hockenberry M, Herman S: Self-hypnosis as an antiemetic therapy in children receiving chemotherapy. Oncol Nurs Forum 1985 (12):41–46.PubMedGoogle Scholar
  62. 62.
    Redd WH, Andresen GV, Minagawa RY: Hypnotic control of anticipatory emesis in patients receiving cancer chemotherapy. J Consult Clin Psychology 1982 (50): 14–19CrossRefGoogle Scholar
  63. 63.
    Syrjala KL, Cummings C, Donaldson GW: Hypnosis or cognitive behavioral training for reduction of pain and nausea during cancer treatment: a controlled clinical trial. Pain 1992 (48): 137–146PubMedCrossRefGoogle Scholar
  64. 64.
    Burish TG, Lyles JN: Effectiveness of relaxation training in reducing adverse reactions to cancer chemotherapy. J Behav Med 1981 (4):65–78PubMedCrossRefGoogle Scholar
  65. 65.
    Lyles JN, Burish TG, Krozely MG, Oldham RK: Efficacy of relaxation training and guided imagery in reducing the aversiveness of cancer chemotherapy. J Consult Clin Psychology 1982 (50):509–524CrossRefGoogle Scholar
  66. 66.
    Burish TG, Carey MP, Krozely MG, Greco FA: Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment. J Consult Clin Psychology 1987 (55):42–48CrossRefGoogle Scholar
  67. 67.
    Carey MP, Burish TG: Providing relaxation training to cancer chemotherapy patients: a comparison of three delivery techniques. J Consult Clin Psychology 1987 (55): 732–737CrossRefGoogle Scholar
  68. 68.
    Cotanch PH: Relaxation training for control of nausea and vomiting in patients receiving chemotherapy. Cancer Nurs 1983 (6):277–283PubMedCrossRefGoogle Scholar
  69. 69.
    Cotanch PH, Strum S: Progressive muscle relaxation as antiemetic therapy for cancer patients. Oncol Nurs Forum 1987 (14):33–37PubMedGoogle Scholar
  70. 70.
    Scott DW, Donahue DC, Mastrovito RC, Hakes TB: Comparative trial of clinical relaxation and an antiemetic drug regimen in reducing chemotherapy-related nausea and vomiting. Cancer Nurs 1986 (9): 178–187CrossRefGoogle Scholar
  71. 71.
    Gralla RJ, Itri LM, Pisko SE et al: Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 1981 (305):905–909PubMedCrossRefGoogle Scholar
  72. 72.
    Holli K: Ineffectiveness of relaxation on vomiting induced by cancer chemotherapy. Eur J Cancer 1993 (29A): 1915–1916PubMedCrossRefGoogle Scholar
  73. 73.
    Wolpe J: The Practice of Behavior Therapy (3rd ed). Pergamon Press, Oxford 1983Google Scholar
  74. 74.
    Reesal RT, Bajramovic H, Mai F: Anticipatory nausea and vomiting: a form of chemotherapy phobia? Can J Psychiatry 1990 (35):80–82PubMedGoogle Scholar
  75. 75.
    Hailey BJ, White JG: Systematic desensitization for anticipatory nausea associated with chemotherapy. Psychosomatic 1983 (24):289–291Google Scholar
  76. 76.
    Hoffman ML: Hypnotic desensitization for the management of anticipatory emesis in chemotherapy. Am J Clin Hypnosis 1982–1983 (25):173–176CrossRefGoogle Scholar
  77. 77.
    Morrow GR, Morrell C: Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. N Engl J Med 1982 (307): 1476–1480PubMedCrossRefGoogle Scholar
  78. 78.
    Morrow GR: Effect of the cognitive hierarchy in the systematic desensitization treatment of anticipatory nausea in cancer patients: a component comparison with relaxation only, counseling, and no treatment. Cogn Ther Res 1986 (10):421–446CrossRefGoogle Scholar
  79. 79.
    Shartner CD, Burish TG, Carey MP: Effectiveness of biofeedback with progressive muscle relaxation training in reducing the aversiveness of cancer chemotherapy: a preliminary report. Jap J Biofeedback Res 1985 (12):33–40Google Scholar
  80. 80.
    Nerenz DR, Leventhal H, Easterling DV, Love RR: Anxiety and taste as predictors of anticipatory nausea in cancer chemotherapy. J Clin Oncol 1986 (4):224–233PubMedGoogle Scholar
  81. 81.
    Moore K, Altmaier EM: Stress inoculation training with cancer patients. Cancer Nurs 1981 (Oct):389–393Google Scholar
  82. 82.
    Frank JM: The effects of music therapy and guided visual imagery on chemotherapy induced nausea and vomiting. Oncology Nursing Forum 1985 (12):47–52PubMedGoogle Scholar
  83. 83.
    Porchet-Munro S: Music therapy in support of cancer patients. In: Senn HJ, Glaus A, Schmid L (eds) Recent Results in Cancer Research: Supportive Care in Cancer Patients. Springer-Verlag, Berlin 1988 pp 289–294Google Scholar
  84. 84.
    Kolko DJ, Rickard-Figueroa JL: Effects of video games on the adverse corollaries of chemotherapy in pediatric oncology patients: a single-case analysis. J Consult Clin Psychology 1985 (53):223–228CrossRefGoogle Scholar
  85. 85.
    Redd WH, Jacobsen PB, Die-Trill M et al: Cognitive/attentional distraction in the control of conditioned nausea in pediatric cancer patients receiving chemotherapy. J Consult Clin Psychology 1987 (55):391–395CrossRefGoogle Scholar
  86. 86.
    Friedlander M, Kearsley JH, Tattersall MHN: Oral lorazepam to improve tolerance of cytotoxic therapy. Lancet 1981 (1):1316–1317PubMedCrossRefGoogle Scholar
  87. 87.
    Bishop JF, Olver IN, Wolf MM et al.: Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine. J Clin Oncol 1984 (2):691–695PubMedGoogle Scholar
  88. 88.
    Razavi D, Delvaux N, Farvacques C et al.: Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. J Clin Oncol 1993 (11):1384–1390PubMedGoogle Scholar
  89. 89.
    Stefanik ME, Sheidler VR, Fetting JH: Anticipatory nausea and vomiting: does it remain a significant problem? Cancer 1988 (62):2654–2657CrossRefGoogle Scholar
  90. 90.
    Grunberg SM, Hesketh PJ: Control of chemotherapy-induced emesis. N Engl J Med 1993 (329): 1790–1796)PubMedCrossRefGoogle Scholar
  91. 91.
    Soukop M, McQuade B, Hunter E et al.: Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer. Oncology 1992 (49):295–304PubMedCrossRefGoogle Scholar
  92. 92.
    Watson M: Anticipatory nausea and vomiting: broadening the scope of psychological treatments. Support Care Cancer 1993 (1): 171–177PubMedCrossRefGoogle Scholar
  93. 93.
    Redd WH: Advances in behavioural intervention in comprehensive cancer treatment. Support Care Cancer 1994 (2):111–115PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • Jørn Herrstedt
    • 1
  1. 1.Department of Medicine/Medical Oncology FHillerød HospitalHillerødDenmark

Personalised recommendations